Want to see HK:7630 full AI Analyst Report?

IMPACT Therapeutics, Inc. Class H (7630) Financial Statements

― Followers

IMPACT Therapeutics, Inc. Class H Financial Overview

IMPACT Therapeutics, Inc. Class H's market cap is currently HK$3.64B. The company's EPS TTM is $; its P/E ratio is -12.45; IMPACT Therapeutics, Inc. Class H is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23
Income Statement
Total Revenue	$ 5.33M	$ 4.68M	$ 33.27M
Gross Profit	$ 4.49M	$ 3.54M	$ 32.14M
Operating Income	$ -32.04M	$ -28.98M	$ -4.00M
EBITDA	$ -31.42M	$ -26.86M	$ -1.60M
Net Income	$ -41.23M	$ -35.54M	$ 519.73K
Balance Sheet
Cash & Short-Term Investments	$ 36.99M	$ 46.59M	$ 38.95M
Total Assets	$ 47.86M	$ 53.26M	$ 43.65M
Total Debt	$ 123.32M	$ 118.21M	$ 0.00
Net Debt	$ 86.33M	$ 86.70M	$ -38.95M
Total Liabilities	$ 184.92M	$ 155.18M	$ 57.10M
Stockholders' Equity	$ -137.06M	$ -101.93M	$ -13.45M
Cash Flow
Free Cash Flow	$ -13.57M	$ -12.28M	$ 3.06M
Operating Cash Flow	$ -13.36M	$ -12.05M	$ 3.10M
Investing Cash Flow	$ 15.68M	$ -57.18M	$ 17.68M
Financing Cash Flow	$ 1.92M	$ 62.55M	$ 5.59M

Currency in USD

IMPACT Therapeutics, Inc. Class H Earnings and Revenue History

Income Statement >

IMPACT Therapeutics, Inc. Class H Debt to Assets

Balance Sheet >

IMPACT Therapeutics, Inc. Class H Cash Flow

Cash Flow >

IMPACT Therapeutics, Inc. Class H Forecast EPS vs Actual EPS

Earnings >